Previous close | 0.8302 |
Open | 0.8490 |
Bid | 0.7422 x 100 |
Ask | 0.7553 x 600 |
Day's range | 0.7316 - 0.8490 |
52-week range | 0.7316 - 8.3700 |
Volume | |
Avg. volume | 1,036,954 |
Market cap | 90.284M |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Scilex Holding ( NASDAQ:SCLX ) Full Year 2023 Results Key Financial Results Revenue: US$46.7m (up 23% from FY 2022...
Key Insights Scilex Holding's significant private companies ownership suggests that the key decisions are influenced by...
Shares of Scilex Holdings (NASDAQ: SCLX) were up around 14% as of 2:30 p.m. ET on Monday. Scilex makes non-opioid pain management products to treat acute and chronic pain. The company's shares gained after it received a buy rating on Monday from H.C. Wainwright analyst Ram Selvaraju with a $12 price target.